Targeting the dysfunctional mitochondrial respiration in drug resistant B-cell acute lymphoblastic leukemia
| Autor: | John M. Hollander, Werner J. Geldenhuys, Quincy A. Hathaway, Rajesh R. Nair, Debbie Piktel, Stephanie L. Rellick, Patrick Thomas, Laura F. Gibson, Pushkar Saralkar, Karen H. Martin |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0303 health sciences
Programmed cell death Stromal cell 3. Good health 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Sodium pyruvate Immune system medicine.anatomical_structure chemistry Cell culture 030220 oncology & carcinogenesis Gene expression medicine Cancer research Bone marrow Reprogramming 030304 developmental biology |
| Popis: | Reprogramming of cellular pathways is a crucial mechanism of drug resistance and survival in refractory acute lymphoblastic leukemia (ALL) cells. In the present study, we performed an unbiased gene expression analysis and identified a dysfunctional mitochondrial respiration program in drug-resistant ALL cells grown in a co-culture system with bone marrow stromal cells (BMSC). Specifically, the activity of the complexes within the electron transport chain was significantly downregulated, correlated with decreased mitochondrial mass and ATP production in drug-resistant ALL cells. To validate mitochondrial respiration as a druggable target, we utilized pyrvinium pamoate (PP), a known inhibitor of mitochondrial respiration and documented its anti-leukemic activity in several ALL cell lines grown alone or in co-culture with BMSC. To increase the bioavailability profile of PP, we successfully encapsulated PP in a nanoparticle drug delivery system and demonstrated that it retained its anti-leukemic activity in a hemosphere assay. PP anti-leukemic activity was decreased by the addition of sodium pyruvate, and furthermore, PP was found to have an additive anti-leukemic effect when used in combination with rotenone, a mitochondrial complex I inhibitor with activity similar to PP on the mitochondrial respiration. Importantly, PP’s cell death activity was found to be specific for leukemic cells as primary normal immune cells were resistant to PP-mediated cell death. In conclusion, we have demonstrated that PP is a novel therapeutic lead compound that counteracts the respiratory reprogramming found in refractory ALL cells. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|